Chen, Yihao
Hu, Rongwei
Jin, Chunchun
Huang, Leidan
Lin, Yiqin
Zou, Bingzi
Liu, Xiaorui
Li, Zhilin
Li, Zhengyi
Liu, Weizong
Funding for this research was provided by:
Medical Scientific Research Foundation of Guangdong Province, China (No. A2023246, No. A2023246)
Shenzhen Science and Technology Program, China (No. JCYJ20220530150801002, RCBS20221008093242056, No. JCYJ20220530150801002, RCBS20221008093242056, No. JCYJ20220530150801002, RCBS20221008093242056)
Huizhou Science and Technology Program, China (No. 2024CZ010130)
Clinical Research Program of Shenzhen Second People's Hospital (No. 2023yjlcyj014, No. 2023yjlcyj014)
Article History
Received: 22 December 2024
Accepted: 28 February 2025
First Online: 14 March 2025
Declarations
:
: This study design followed the international regulations of the Helsinki Declaration. Our research was approved by the Ethics Committee of Shenzhen Second People’s Hospital (20220518002–FS01) and registered in the Chinese Clinical Trial Registry (ChiCTR2200063200). Written informed consent was obtained from all participants.
: Not applicable.
: The authors declare no competing interests.